Intercept Pharmaceuticals, Inc.

JPMORGAN CHASE & CO

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

289,771

Value ($000)

5,372

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	5,372	0.0%	289,771	9/30/2023
2023 Q2	8/11/2023	329	0.0%	29,772	6/30/2023
2023 Q1	5/18/2023	2,625	0.0%	195,468	3/31/2023
2022 Q4	2/13/2023	4,908	0.0%	396,803	12/31/2022
2022 Q3	11/14/2022	2,425	0.0%	173,851	9/30/2022
2022 Q2	8/11/2022	4,488	0.0%	324,980	6/30/2022
2022 Q1	5/11/2022	4,970	0.0%	305,441	3/31/2022
2021 Q4	2/11/2022	2,989	0.0%	183,486	12/31/2021
2021 Q3	11/12/2021	2,944	0.0%	198,312	9/30/2021
2021 Q2	8/12/2021	22,144	0.0%	1,108,855	6/30/2021
2021 Q1	5/12/2021	22,281	0.0%	965,351	3/31/2021
2020 Q4	2/19/2021	32,560	0.0%	1,318,215	12/31/2020
2020 Q3	11/12/2020	52,416	0.0%	1,254,550	9/30/2020
2020 Q2	8/11/2020	75,631	0.0%	1,578,602	6/30/2020
2020 Q1	5/12/2020	92,510	0.0%	1,469,343	3/31/2020
2019 Q4	2/11/2020	188,905	0.0%	1,524,413	12/31/2019
2014 Q1	5/15/2014	16,107	0.0%	48,837	3/31/2014